Pyridostigmine is a cholinesterase inhibitor used to treat myasthenia gravis, a neuromuscular disorder characterized by muscle weakness. It enhances communication between nerves and muscles by preventing the breakdown of acetylcholine. Its clinical relevance lies in improving muscle strength and function. In summary, Pyridostigmine is crucial for managing neuromuscular disorders.
Pyridostigmine inhibits acetylcholinesterase, increasing acetylcholine levels at the neuromuscular junction and enhancing muscle contraction.


